The aim of this review is to summarize present evidence of an association between
circulating levels of C-reactive protein (CRP) and cancer risk, and to evaluate whether …

Elevated plasma levels of C-reactive protein (CRP), a marker of inflammation, are
associated with an increased risk of cancer, but it is unclear whether this association is …

Purpose We tested the hypothesis that baseline plasma levels of C-reactive protein (CRP)
are associated with risk of incident cancer in the general population and early death in …

The objective of this study was to review and summarise the published evidence for an
association between circulating concentrations of C reactive protein (CRP) and cancer …

Purpose It remains unclear if inflammation itself may induce cancer, if inflammation is a
result of tumor growth, or a combination of both exists. The aim of this study was to examine …

Background: Inflammation is an important component of carcinogenesis but little research
has been conducted on whether inflammation markers can be predictive of cancer risk in …

Introduction We examined whether plasma C-reactive protein (CRP) levels at the time of
diagnosis of breast cancer are associated with overall survival, disease-free survival, death …

Background: Associations between elevated C-reactive protein (CRP) and cancer risk have
been reported for many years, but the results from prospective cohort studies remains …

Purpose Chronic inflammation could play a role in lung carcinogenesis, underscoring the
potential for lung cancer prevention and screening. We investigated the association of …

Background Although observational studies have reported associations between serum C-
reactive protein (CRP) concentration and risks of lung, breast, and colorectal cancer …